IMO it dropped not because of the investigation, but because of the dilution some knew where coming. We saw a big dump prior to the 2nd public offering. The SEC investigation was a non-issue to me because I'm not investing in this company based on their earnings right now, but on the future earnings of getting tedizolid approved. I could care less about accounting practices used to account for payments paid via the partnership.
I think the 2 analyst reiterations from this week are great news. This stock should take off soon.